NGS联合TGS技术在红细胞血型库建设中的应用

丁梦圆 ,  高鑫 ,  王仪含 ,  李少博 ,  汤龙海 ,  江妮娜

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (8) : 1110 -1116.

PDF (1327KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (8) : 1110 -1116. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.08.017
论著

NGS联合TGS技术在红细胞血型库建设中的应用

作者信息 +

Application of combined NGS and TGS technologies in red blood cell blood group bank construction:a preliminary study

Author information +
文章历史 +
PDF (1358K)

摘要

目的 采用二代测序(next-generation sequencing,NGS)对献血者 42 个血型系统进行大规模基因分型,评估其在献血者多系统血型鉴定及稀有血型库建设中的适用性;同时,针对 ABO 正反定型不符的疑难标本,探索三代测序(third-generation sequencing,TGS)在单倍体定相和深度不足区域变异捕获中的补充价值。方法 以某血站 562 名固定献血者为研究对象(中位献血 11 次),采用 NGS 对 42 个血型系统进行基因分型,重点分析 MNS、Lutheran、Kell、Duffy、Kidd、Diego、Yt、Colton、Gerbich、Ok、H、I 共 12 个建库必要系统的表型频率;对 12 例 ABO 正反定型不符标本进行 TGS 复核以解决单倍体定相(haplotype phasing,即确定不同突变位点是否位于同一条染色体上) 问题;并对 MNS、Duffy、Kidd、Lewis 及 ABO 系统行血清学与基因分型比对。结果 NGS 分型显示,Duffy 系统 Fy(a-b+)占 0.87%(4/458),Diego 系统 Di(a+b+)占 10.62%(31/292);Lutheran、Kell、Yt、Colton、H、Ok、I 及 Gerbich 系统呈近乎单一表型分布。 12 例 ABO 疑难标本中,5 例 NGS 因无法定相给出多种基因型组合,TGS 通过长读长唯一确定基因型;1 例 NGS 因测序深度不足仅检出 2 个突变位点,TGS 完整检出 11 个位点并明确分型为 A1。 血清学与基因分型一致率分别为:Duffy 96.55%(140/145)、ABO 96.43%(513/532)、Kidd 94.17%(97/103)、MNS 85.07%(57/67)、Lewis 68.18%(75/110)。 MNS 系统 8 例血清学 M+N+而基因型为 M-N+的标本中,7 例携带 GYPB 变异;Lewis 系统不一致标本主要为基因型 Le(a-b+)而血清学呈其他表型。 NGS 平台可在2 周内完成192 个标本测序。结论 NGS 联合 TGS 及血清学的分层分型策略可在大规模献血者中完成多系统血型鉴定,TGS 在 ABO 疑难标本定相和深度不足区域变异捕获上具有补充价值。 本研究为本地稀有血型库扩容提供了技术框架和基础频率数据,但策略的标准化和成本效益需扩大标本验证,且对 Lewis 等分泌相关系统应保留血清学复核。

Abstract

Objective This study employed next-generation sequencing (NGS) for large-scale genotyping of 42 blood group systems in blood donors to evaluate its applicability in multi-system blood group identification and rare blood type repository construction, while exploring the complementary value of third-generation sequencing (TGS) in haplotype phasing and variant capture in regions with insufficient sequencing depth for ABO ambiguous samples. Methods A total of 562 regular blood donors (median donation frequency 11 times) from a blood center were enrolled. NGS was used for genotyping of 42 blood group systems, with a focused analysis on 12 systems essential for rare blood type repository construction:MNS, Lutheran, Kell, Duffy, Kidd, Diego, Yt, Colton, Gerbich, Ok, H, and I. TGS was employed to resolve haplotype phasing (i. e. , determining whether different mutation sites are located on the same chromosome) in 12 ABO samples with discrepancies between forward and reverse typing. Serological and genotyping results were compared for MNS, Duffy, Kidd, Lewis, and ABO systems. Results NGS-based genotyping revealed that Fy(a-b+) in the Duffy system accounted for 0.87% (4/458), and Di(a+b+) in the Diego system accounted for 10.62% (31/292). The Lutheran, Kell, Yt, Colton, H, Ok, I, and Gerbich systems exhibited near-uniform phenotype distributions. Among the 12 ABO ambiguous samples, NGS yielded multiple possible genotype combinations in 5 cases due to inability to phase alleles, whereas TGS uniquely resolved the genotypes through long-read sequencing. In one case, NGS detected only 2 mutation sites due to insufficient sequencing depth, while TGS identified all 11 sites and assigned the A1 phenotype. Concordance rates between serology and genotyping were:Duffy 96.55% (140/145), ABO 96.43% (513/532), Kidd 94.17% (97/103), MNS 85.07% (57/67), and Lewis 68.18% (75/110). In the MNS system, 7 of 8 samples serologically typed as M+N+ but genotyped as M-N+ carried GYPB variants. Lewis discrepancies predominantly featured genotype Le(a-b+) with serological phenotypes of Le(a+b-), Le(a+b+), or Le(a-b-). The NGS platform completed sequencing of 192 samples within 2 weeks. Conclusion The tiered genotyping strategy combining NGS, TGS, and serology enables multi-system blood group identification in large-scale blood donor populations. TGS provides complementary value in phasing ambiguous ABO samples and detecting variants in regions with insufficient sequencing depth. This study provides a technical framework and baseline frequency data for the expansion of a local rare blood type repository. However, standardization and cost-effectiveness of this strategy require further validation with expanded sample sizes, and serological confirmation should be retained for secretion status-related systems such as Lewis.

关键词

NGS / TGS / 稀有血型 / 血型基因分型 / 献血者

Key words

next-generation sequencing / third-generation sequencing / rare blood types / blood group genotyping / blood donors

引用本文

引用格式 ▾
丁梦圆,高鑫,王仪含,李少博,汤龙海,江妮娜. NGS联合TGS技术在红细胞血型库建设中的应用[J]. 中国输血杂志, 2026, 39(8): 1110-1116 DOI:10.13303/j.cjbt.issn.1004-549x.2026.08.017

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

朱自严, 王晨, 叶璐夷, 等. 红细胞稀有血型筛选、建库与应用[C]//中国输血协会第六届输血大会论文集. 广州, 2012.

[2]

ZHU Z Y, WANG C, YE L Y, et al. Screening, database construction and application of rare red blood cell blood groups[C]//Proceedings of the 6th Annual Congress of Chinese Society of Blood Transfusion. Guangzhou, 2012.

[3]

杜飞嫦, 洪文旭, 吴凡. 稀有血型库和血小板供者资料库的研究进展[J].检验医学与临床, 2021, 18(2):276-278.

[4]

DU F C, HONG W X, WU F. Research progress on rare blood type database and platelet donor database[J].Lab Med Clin, 2021, 18(2):276-278.

[5]

CHEN C, TAN J, WANG L, et al. Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review[J].Transfusion, 2016, 56(4):975-979.

[6]

褚晓月, 张泳, 毛娟, 等. 陕西省 Kidd、Diego、Duffy 血型数据库的建立及临床应用研究[J].中国输血杂志, 2022, 35(11):1124-1127.

[7]

CHU X Y, ZHANG Y, MAO J, et al. Establishment and clinical application of Kidd, Diego and Duffy blood group database in Shaanxi Province[J].Chin J Blood Transfusion, 2022, 35(11):1124-1127.

[8]

赵瑛, 圣孟华, 郝明葳, 等. 大数据背景下稀有血型数据库建设与管理的研究进展[J].医学理论与实践, 2023, 36(19):3280-3282.

[9]

ZHAO Y, SHENG M H, HAO M W, et al. Research progress on construction and management of rare blood type databases in the context of big data[J].Med Theory Pract, 2023, 36(19):3280-3282.

[10]

裘君娜, 孔长虹, 许先国,等. 基于数据建模的浙江省稀有血型信息共享系统构建与应用[J].中国输血杂志, 2024, 37(9):1068-1072.

[11]

QIU J N, KONG C H, XU X G, et al. Construction and application of rare blood type information sharing system in Zhejiang Province based on data modeling[J].Chin J Blood Transfusion, 2024, 37(9):1068-1072.

[12]

张兵, 徐罡, 胡文健, 等. 建立基于 qPCR 技术的红细胞 Diego、MNS、Kell 血型基因分型方法及初步应用[J].中国实验血液学杂志, 2025, 33(5):1429-1434.

[13]

ZHANG B, XU G, HU W J, et al. Establishment and preliminary application of qPCR-based genotyping methods for red blood cell Diego, MNS and Kell blood group systems[J].J Exp Hematol, 2025, 33(5):1429-1434.

[14]

KROG G R, RIENECK K, CLAUSEN F B, et al. Blood group genotyping of blood donors:validation of a highly accurate routine method[J].Transfusion, 2019, 59(10):3264-3274.

[15]

PEYRARD T, PHAM B N, LE PENNEC P Y, et al. The rare blood groups: a public health challenge[J].Transfus Clin Biol, 2008, 15(3):109-119.

[16]

FÜRST D, TSAMADOU C, NEUCHEL C, et al. Next-generation sequencing technologies in blood group typing[J].Transfus Med Hemother, 2020, 47(1):4-13.

[17]

WESTHOFF C M, FLOCH A. Blood group genotype matching for transfusion[J].Br J Haematol, 2025, 206(1):18-32.

[18]

尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 第 5 版.北京:人民卫生出版社, 2023.

[19]

SHANG H, WANG Y S, SHEN Z Y. National clinical laboratory operating procedures[M]. 5th ed. Beijing: People′s Medical Publishing House,2023.

[20]

丁佳栋, 王艺媛, 张晓萍. 甘肃省东乡族 12 个稀有血型系统基因多态性初探[J].中国实验血液学杂志, 2025, 33(2):552-556.

[21]

DING J D, WANG Y Y, ZHANG X P. Preliminary study on genetic polymorphisms of 12 rare blood group systems in Dongxiang ethnic group of Gansu Province[J].J Exp Hematol, 2025, 33(2):552-556.

[22]

LOMAS-FRANCIS C, THORNTON N, NANCE S T. The need for rare blood programs is real[J].Transfusion, 2023, 63(4):659-664.

[23]

MARTIN W, SYLVIA M, MAIKE B, et al. Regulation of the Lewis blood group antigen expression:a literature review supplemented with computational analysis[J].Transfus Med Hemother, 2024, 51(4):225-236.

[24]

VORHOLT S M, LENZ V, JUST B, et al. High-throughput next-generation sequencing of the Kidd blood group:unexpected antigen expression properties of four alleles and detection of novel variants[J].Transfus Med Hemother, 2023, 50(1):51-65.

基金资助

苏州市应用基础研究重点项目(SYW2025024)

苏州市应用基础研究重点项目(SYW2025025)

苏州市卫健委面上项目(MSXM2024040)

苏州市卫健委重点项目(ZDXM2025020)

苏州市预防医学会科技项目(SZSYFYXH-KJ-ZD2026-29)

AI Summary AI Mindmap
PDF (1327KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉